Navigation Links
Exelixis Announces January 31 Webcast of Presentation at the 2008 Wachovia Healthcare Conference
Date:1/24/2008

SOUTH SAN FRANCISCO, Calif., Jan. 24 /PRNewswire-FirstCall/ -- Exelixis, Inc. (Nasdaq: EXEL) announced today that George A. Scangos, Ph.D., president and chief executive officer of Exelixis, will present at the 2008 Wachovia Healthcare Conference at 9:30 a.m. ET / 6:30 a.m. PT on Thursday, January 31, 2008.

The presentation will be webcast and may be accessed in the Event Calendar page under Investors on the Exelixis website at http://www.exelixis.com.

About Exelixis

Exelixis, Inc. is a development-stage biotechnology company dedicated to the discovery and development of novel small molecule therapeutics for the treatment of cancer and other serious diseases. The company is leveraging its fully integrated drug discovery platform to fuel the growth of its development pipeline, which is primarily focused on cancer. Currently, Exelixis' broad product pipeline includes investigational compounds in phase 2 and phase 1 clinical development. Exelixis has established strategic corporate alliances with major pharmaceutical and biotechnology companies, including GlaxoSmithKline, Bristol-Myers Squibb Company, Genentech, Wyeth Pharmaceuticals and Daiichi-Sankyo. For more information, please visit the company's web site at http://www.exelixis.com.


'/>"/>
SOURCE Exelixis, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Exelixis Announces Senior Management Promotions
2. Exelixis Announces January 10 Webcast of Presentation at the 26th Annual JPMorgan Healthcare Conference
3. Exelixis Submits XL139 Diligence Report to Bristol-Myers Squibb
4. Reminder: Exelixis Announces December 5 Webcast of Its Third Annual R&D Day
5. Exelixis Announces November 28 Webcast of Presentation at the Lazard Capital Markets Fourth Annual Healthcare Conference
6. Exelixis Announces November 27 Webcast of Presentation at the 19th Annual Piper Jaffray Health Care Conference
7. Exelixis Announces December 5 Webcast of Its Third Annual R&D Day
8. Exelixis Sells 80% Stake in Artemis to Taconic
9. Exelixis Announces Third Quarter 2007 Financial Results and Business Update
10. Exelixis Announces November 5 Webcast of its 2007 Third Quarter Financial Results Conference Call
11. Exelixis Submits XL880 Diligence Report to GlaxoSmithKline
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... 2014 EquitiesIQ, a leading informational research ... Alliqua is an emerging biomedical company acquiring, developing, manufacturing, ... market. , Free report download: http://equitiesiq.com/reports/alliqua/ , ... management team and Board, which launched the company’s new ...
(Date:1/14/2014)... In recent years, growing suspicion about ... product development and promotion has led to unprecedented levels ... by concerns about the insidious impact of commercialization of ... fines to the world’s biggest pharmas for illegal marketing ...
(Date:1/14/2014)... UK (PRWEB) January 13, 2014 Bob ... with more than 20 years in the industry, has ... photonics . Hainsey will serve as the society’s Science ... Dr. Hainsey join SPIE as our Technology Strategist, further ...
(Date:1/14/2014)... BioMedomics, Inc. , a Point of Care ... novel disease specific POC tests, announced today that it has ... of $690,000. The investment is from private investors and is ... of private investors has significant successful experience in early investments ...
Breaking Biology Technology:EquitiesIQ Initiates Coverage of Alliqua, Inc. 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 3The Sunshine Act: Necessary Regulation or Unnecessary Dysregulation? New Life Science Webinar Hosted by Xtalks and IRB Services 2The Sunshine Act: Necessary Regulation or Unnecessary Dysregulation? New Life Science Webinar Hosted by Xtalks and IRB Services 3Photonics R&D Leader Bob Hainsey Joins SPIE Technical Staff 2BioMedomics, Inc. Closes $690K Round of Financing 2
... economy by producing and attracting human capital. Is America ... opens Richard Floridas article, Americas Looming Creativity Crisis, which ... Business Review. (The full text of the article can ... well known for his writings about the economic importance ...
... the State University of New York in Albany, Carlos Santiago ... led to the creation of a $1.5 billion center of ... Santiago sees no reason why UW-Milwaukee can't aspire to do ... the new chancellor of UW-Milwaukee, is determined to build the ...
... star. In this case, he was a world-renowned scientist for ... around to sing his deserving praise. , ,I only became ... of biotech scientist Benjamin Frydman, who passed away due to ... by birth, Frydman was a founder of Wisconsin biotech company ...
Cached Biology Technology:Is America Inc.s brand diminishing? 2Is America Inc.s brand diminishing? 3Is America Inc.s brand diminishing? 4UW-Milwaukee Chancellor Santiago determined to build on research base 2UW-Milwaukee Chancellor Santiago determined to build on research base 3An Argentine biotechman in Wisconsin 2An Argentine biotechman in Wisconsin 3An Argentine biotechman in Wisconsin 4
(Date:4/18/2014)... researchers have published soil organic carbon sequestration rates. ... organic carbon can be sequestered by simply switching from ... there is a growing body of research with evidence ... cover crops, small grains, and forages may not be ... , "Some studies have shown that both moldboard and ...
(Date:4/18/2014)... Calif. A team of researchers led by ... been selected to receive a $7.5 million Department of ... simple and basic scientific foundations for the predictable design ... a wide diversity of structures from plants and animals, ... are taking what biological systems have constructed over millions ...
(Date:4/17/2014)... Suddenly there was a word for chili peppers. Information ... along with a study of the appearance of words ... understand where jalapeos were domesticated and highlight the value ... (Kraig Kraft et al.) of nine papers presented in ... the National Academy of Sciences on plant and ...
Breaking Biology News(10 mins):Researchers question published no-till soil organic carbon sequestration rates 2Researchers question published no-till soil organic carbon sequestration rates 3Researchers question published no-till soil organic carbon sequestration rates 4Mantis shrimp, toucan and trilobite, oh my 2Mantis shrimp, toucan and trilobite, oh my 3Chickens to chili peppers 2Chickens to chili peppers 3
... largest mass extinction which killed more than 70 percent ... still taking lives today. That,s the conclusion of a new ... content of coal in one region of China may be ... high rates of lung cancer. The study, which helps solve ...
... reporting new evidence that certain high blood pressure drugs may ... cause of vision loss in people with diabetes. The study, ... lead to new ways to prevent or treat the sight-threatening ... of Proteome Research , a monthly publication. Edward ...
... we chew our food? Research has shown that it is not, ... enough to swallow without choking. Biomechanics, who have modelled the ... shown that we actually chew our food to ensure it is ... in January,s Physics World , Dr Roland Ennos, a biomechanic ...
Cached Biology News:How people work ... and the fingerprint mystery 2
acridine orange 10-nonyl bromide (nonyl acridine orange)...
anti-dansyl, rabbit IgG fraction *1 mg/mL* Secondary Detection; Anti-Dye and Anti-Hapten Antibodies...
Because it is manufactured at our ISO 9001–certified facilities in Eugene, Oregon, we can guarantee that FluoroPure grade propidium iodide is greater than or equal to 98% pure by HPLC....
MOUSE ANTI RAT RT1Ac Immunogen: PHA activated rat lymphocytes...
Biology Products: